Pharmacy Practice
Affordable Medicines
Compliance
Compounding
Drug Approvals
Geriatrics
Hospital/Health System
In-Pharmacy Vaccines
Law
Medication Management
News & Trends
OTC
Specialty Pharmacy
Technology
Disease State
Allergy
Autoimmune
Breast Cancer
Cardiovascular
Cold & Flu
Dermatology
Diabetes
Gastroenterology
Hematology
HIV/AIDS
Infectious Disease
Lung Cancer
Mental Health
Neurology
Oncology
Ophthalmology
Orthopedics
Pain Management
Pediatrics
Respiratory
Urology/Nephrology
Women’s Health
Videos
Patient Teaching Aid
Publications
Featured Issue
Featured Supplements
Conference Coverage
Continuing Education
Subscribe
COVID-19 Resources
DIABETES
February 24, 2021
COVID-19 and Metformin: What Diabetes Patients Need to Know
February 3, 2021
Metformin Appears Protective Against Some, But Not All, Breast Cancer Types
January 27, 2021
Poor Glycemic Control Raises Risk of Infections in Diabetes Patients
January 20, 2021
Endocrine Society Makes Big Push to Lower Fast-Rising Insulin Prices
January 6, 2021
Should COVID-19 Patients Discontinue Use of SGLT2 Inhibitors for Diabetes?
December 16, 2020
Metformin Appears to Reduce COVID-19 Mortality Risk in Women With Diabetes
November 25, 2020
Empagliflozin Also Beneficial in Heart-Failure Patients Without Diabetes
November 13, 2020
Why Respiratory Infections Prove More Deadly in Diabetes Patients
November 13, 2020
Continuous Glucose Monitoring
November 13, 2020
Diabetes Trends During Pregnancy
November 13, 2020
The Effect of COVID-19 on Patients With Diabetes
November 13, 2020
Managing the Complications of Diabetes
November 13, 2020
Hypoglycemia Prevention and Treatment in the Ambulatory Care Setting
Load More
X
February 2021
In This Issue
Digital Magazine
Archives
Subscription
Related CE
$6.97 Per CE Exam or $59 for 12 Lessons
Medication Adherence in Patients With Type 2 Diabetes
Oral Semaglutide: A New GLP-1 Receptor Agonist Product for the Treatment of Type 2 Diabetes
×
Full Image